Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC, Stage I”

1,315 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,315 results

Large-scale testing (Phase 3)Study completedNCT00775307
What this trial is testing

Adjuvant Pazopanib in Stage I NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 142
Testing effectiveness (Phase 2)Study completedNCT03046992
What this trial is testing

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Who this might be right for
EGFR Gene Mutation
Yuhan Corporation 224
Early research (Phase 1)Study completedNCT02009436
What this trial is testing

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 8
Testing effectiveness (Phase 2)Study completedNCT03562871
What this trial is testing

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Who this might be right for
NSCLC
IO Biotech 109
Early research (Phase 1)Study completedNCT01346540
What this trial is testing

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16
Large-scale testing (Phase 3)UnknownNCT02011997
What this trial is testing

Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion

Who this might be right for
Non-small Cell Lung Cancer Stage ILung Adenocarcinoma
The First Affiliated Hospital of Guangzhou Medical University 500
Large-scale testing (Phase 3)Study completedNCT00003831
What this trial is testing

Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 1,023
Testing effectiveness (Phase 2)Ended earlyNCT00004093
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Northwestern University 36
Early research (Phase 1)Looking for participantsNCT06046495
What this trial is testing

The Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Avistone Biotechnology Co., Ltd. 81
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04656769
What this trial is testing

Analgesia aNd caNcer recUrrence Lung cAncer Resection

Who this might be right for
Recurrence TumorOpioid Use, UnspecifiedAnalgesia+1 more
University of Turin, Italy 382
Not applicableLooking for participantsNCT07554677
What this trial is testing

Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study

Who this might be right for
Lung Cancer
Queen's University, Belfast 30
Early research (Phase 1)Looking for participantsNCT06800339
What this trial is testing

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Maryland, Baltimore 18
Early research (Phase 1)Ended earlyNCT02987998
What this trial is testing

Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC

Who this might be right for
Stage IIIA Non-Small Cell Lung Cancer
Nathan Pennell, MD, PhD 9
Large-scale testing (Phase 3)Study completedNCT00475098
What this trial is testing

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 553
Early research (Phase 1)Study completedNCT03801902
What this trial is testing

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaLocally Recurrent Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8+2 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Study completedNCT00514007
What this trial is testing

Study of Continuous OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Large-scale testing (Phase 3)Study completedNCT01124253
What this trial is testing

Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Jiao Tong University School of Medicine 250
Early research (Phase 1)Study completedNCT02592577
What this trial is testing

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerCarcinoma
Adaptimmune 28
Next Page